Cola Intake Increases Exposure of Erlotinib

This article originally appeared here.
Share this content:
Cola Intake Increases Exposure of Erlotinib
Cola Intake Increases Exposure of Erlotinib

WEDNESDAY, Feb. 10, 2016 (HealthDay News) -- Cola intake leads to a clinically relevant and statistically significant increase in the bioavailability of erlotinib during esomeprazole treatment, according to a study published online Feb. 8 in the Journal of Clinical Oncology.

Roelof W.F. van Leeuwen, Pharm.D., from the Erasmus Medical Center Cancer Institute in Rotterdam, Netherlands, and colleagues conducted a randomized, cross-over, pharmacokinetic study of 28 patients with non-small-cell lung cancer. Intrapatient differences were evaluated for absorption (area under the plasma concentration time curve [AUC0-12h]) after a seven-day period of concomitant treatment with erlotinib, with or without esomeprazole, with either cola or water.

The researchers found that in patients treated with erlotinib and esomeprazole with cola, the mean AUC0-12h increased 39 percent (P = 0.004). However, in patients not treated with esomeprazole, the mean AUC0-12h was only slightly higher (9 percent; P = 0.03) after erlotinib intake with cola.

"Potentially, the effects of cola on erlotinib exposure may be extrapolated to other tyrosine kinase inhibitors with a pH-dependent solubility (e.g., dasatinib, gefitinib, nilotinib), but this remains to be evaluated in future studies," the authors write. "Furthermore, other acidic beverages (i.e., orange juice, other carbonated drinks) may have similar effects as cola and should be explored in future trials."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »